Epstein-Barr Virus Suppresses a G₂/M Checkpoint Activated by Genotoxins

REFERENCES

• Agami, R., Blandino, G., Oren, M., and Shaul, Y.. 1999. Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis. Nature 399:809–813
   PubMedGoogle Scholar
• Allday, M. J., Inman, G. J., Crawford, D. H., and Farrell, P. J.. 1995. DNA damage in human B cells can induce apoptosis, proceeding from G1/S when p53 is transactivation competent and G2/M when it is transactivation defective. EMBO J. 14:4994–5005
   PubMed Web of Science ®Google Scholar
• Allday, M. J., Sinclair, A., Parker, G., Crawford, D. H., and Farrell, P. J.. 1995. Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53. EMBO J. 14:1382–1391
   PubMed Web of Science ®Google Scholar
• Blasina, A., Paegle, E. S., and McGowan, C. H.. 1997. The role of inhibitory phosphorylation of CDC2 following DNA replication block and radiation-induced damage in human cells. Mol. Biol. Cell 8:1013–1023
   PubMedGoogle Scholar
• Brown, J. M., and Wouters, B. G.. 1999. Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res. 59:1391–1399
   PubMed Web of Science ®Google Scholar
• Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., and Vogelstein, B.. 1998. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282:1497–1501
   PubMed Web of Science ®Google Scholar
• Busch, L. K., and Bishop, G. A.. 1999. The EBV transforming protein, latent membrane protein 1, mimics and cooperates with CD40 signaling in B lymphocytes. J. Immunol. 162:2555–2561
   PubMed Web of Science ®Google Scholar
• Canman, C. E., and Kastan, M. B.. 1996. Signal transduction. Three paths to stress relief. Nature 384:213–214
   PubMed Web of Science ®Google Scholar
• Casciola-Rosen, L., Nicholson, D. W., Chong, T., Rowan, K. R., Thornberry, N. A., Miller, D. K., and Rosen, A.. 1996. Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J. Exp. Med. 183:1957–1964
   PubMed Web of Science ®Google Scholar
• Chen, W., and Cooper, N. R.. 1996. Epstein-Barr virus nuclear antigen 2 and latent membrane protein independently transactivate p53 through induction of NF-κB activity. J. Virol. 70:4849–4853
   PubMedGoogle Scholar
• Devergne, O., McFarland, E. C., Mosialos, G., Izumi, K. M., Ware, C. F., and Kieff, E.. 1998. Role of the TRAF binding site and NF-κB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression. J. Virol. 72:7900–7908
   PubMed Web of Science ®Google Scholar
• Di Como, C. J., Gaiddon, C., and Prives, C.. 1999. p73 function is inhibited by tumor-derived p53 mutants in mammalian cells. Mol. Cell. Biol. 19:1438–1449
   PubMed Web of Science ®Google Scholar
• Eliopoulos, A. G., Dawson, C. W., Mosialos, G., Floettmann, J. E., Rowe, M., Armitage, R. J., Dawson, J., Zapata, J. M., Kerr, D. J., Wakelam, M. J., Reed, J. C., Kieff, E., and Young, L. S.. 1996. CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr virus-encoded LMP1: involvement of TRAF3 as a common mediator. Oncogene 13:2243–2254
   PubMed Web of Science ®Google Scholar
• Falk, M. H., Trauth, B. C., Debatin, K. M., Klas, C., Gregory, C. D., Rickinson, A. B., Calender, A., Lenoir, G. M., Ellwart, J. W., Krammer, P. H. et al. 1992. Expression of the APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype. Blood 79:3300–3306
   PubMed Web of Science ®Google Scholar
• Farrell, P. J.. 1998. Signal transduction from the Epstein-Barr virus LMP-1 transforming protein. Trends Microbiol. 6:175–177
   PubMedGoogle Scholar
• Finke, J., Rowe, M., Kallin, B., Ernberg, I., Rosen, A., Dillner, J., and Klein, G.. 1987. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines. J. Virol. 61:3870–3878
   PubMed Web of Science ®Google Scholar
• Fisher, D. E.. 1994. Apoptosis in cancer therapy: crossing the threshold. Cell 78:539–542
   PubMed Web of Science ®Google Scholar
• Friedberg, E. C., Walker, G. C., and Siede, W.. 1995. DNA repair and mutagenesis 19–47 ASM Press, Washington, D.C.
   Google Scholar
• Fries, K. L., Miller, W. E., and Raab-Traub, N.. 1996. Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene. J. Virol. 70:8653–8659
   PubMed Web of Science ®Google Scholar
• Giaccia, A., and Kastan, M.. 1998. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 12:2973–2983
   PubMed Web of Science ®Google Scholar
• Gong, J. G., Costanzo, A., Yang, H. Q., Melino, G., Kaelin, W. G.Jr., Levrero, M., and Wang, J. Y.. 1999. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 399:806–809
   PubMed Web of Science ®Google Scholar
• Gregory, C. D., Dive, C., Henderson, S., Smith, C. A., Williams, G. T., Gordon, J., and Rickinson, A. B.. 1991. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 349:612–614
   PubMed Web of Science ®Google Scholar
• Han, Z., Chatterjee, D., He, D. M., Early, J., Pantazis, P., Wyche, J. H., and Hendrickson, E. A.. 1995. Evidence for a G2 checkpoint in p53-independent apoptosis induction by X irradiation. Mol. Cell. Biol. 15:5849–5857
   PubMedGoogle Scholar
• Hartwell, L. H., and Kastan, M. B.. 1994. Cell cycle control and cancer. Science 266:1821–1828
   PubMed Web of Science ®Google Scholar
• He, J., Whitacre, C. M., Xue, L. Y., Berger, N. A., and Oleinick, N. L.. 1998. Protease activation and cleavage of poly(ADP-ribose) polymerase: an integral part of apoptosis in response to photodynamic treatment. Cancer Res. 58:940–946
   PubMedGoogle Scholar
• Henderson, S., Rowe, M., Gregory, C., Croom-Carter, D., Wang, F., Longnecker, R., Kieff, E., and Rickinson, A.. 1991. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107–1115
   PubMed Web of Science ®Google Scholar
• Hollstein, M., Shomer, B., Greenblatt, M., Soussi, T., Hovig, E., Montesano, R., and Harris, C. C.. 1996. Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acids Res. 24:141–146
   PubMed Web of Science ®Google Scholar
• Jin, P., Gu, Y., and Morgan, D. O.. 1996. Role of inhibitory CDC2 phosphorylation in radiation-induced G2 arrest in human cells. J. Cell Biol. 134:963–970
   PubMedGoogle Scholar
• Kieff, E.. Epstein-Barr Virus and its replication Fields virology Fields, B. N., Knipe, D. M., and Howley, P. M. 2:2343–2396 Lippincott-Raven, Philadelphia, Pa
   Google Scholar
• Kilger, E., Kieser, A., Baumann, M., and Hammerschmidt, W.. 1998. 1996. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which stimulates an activated CD40 receptor. EMBO J. 17:1700–1709
   PubMed Web of Science ®Google Scholar
• Ko, L. J., and Prives, C.. 1996. p53: puzzle and paradigm. Genes Dev. 10:1054–72
   PubMed Web of Science ®Google Scholar
• Laherty, C. D., Hu, H. M., Opipari, A. W., Wang, F., and Dixit, V. M.. 1992. The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B. J. Biol. Chem. 267:24157–24160
   PubMed Web of Science ®Google Scholar
• Lalle, P., Moyret-Lalle, C., Wang, Q., Vialle, J. M., Navarro, C., Bressac-de Paillerets, B., Magaud, J. P., and Ozturk, M.. 1995. Genomic stability and wild-type p53 function of lymphoblastoid cells with germ-line p53 mutation. Oncogene 10:2447–2454
   PubMedGoogle Scholar
• Lenoir, G., and Bornkamm, G.. 1987. Burkitt's lymphoma, a human model for the multistep development of cancer: proposal for a new scenario. Adv. Viral Oncol. 6:173–205
   Google Scholar
• Levine, A. J.. 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323–331
   PubMed Web of Science ®Google Scholar
• Li, F., Ambrosini, G., Chu, E. Y., Plescia, J., Tognin, S., Marchisio, P. C., and Altieri, D. C.. 1998. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396:580–584
   PubMed Web of Science ®Google Scholar
• Liu, Z. G., Baskaran, R., Lea-Chou, E. T., Wood, L. D., Chen, Y., Karin, M., and Wang, J. Y.. 1996. Three distinct signalling responses by murine fibroblasts to genotoxic stress. Nature 384:273–276
   PubMed Web of Science ®Google Scholar
• Lowe, S. W., Bodis, S., McClatchey, A., Remington, L., Ruley, H. E., Fisher, D. E., Housman, D. E., and Jacks, T.. 1994. p53 status and the efficacy of cancer therapy in vivo. Science 266:807–810
   PubMed Web of Science ®Google Scholar
• Lowe, S. W., Ruley, H. E., Jacks, T., and Housman, D. E.. 1993. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957–967
   PubMed Web of Science ®Google Scholar
• Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., and Jacks, T.. 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847–849
   PubMed Web of Science ®Google Scholar
• Mann, K. P., Staunton, D., and Thorley-Lawson, D. A.. 1985. Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells. J. Virol. 55:710–720
   PubMedGoogle Scholar
• Okan, I., Wang, Y., Chen, F., Hu, L. F., Imreh, S., Klein, G., and Wiman, K. G.. 1995. The EBV-encoded LMP1 protein inhibits p53-triggered apoptosis but not growth arrest. Oncogene 11:1027–1031
   PubMed Web of Science ®Google Scholar
• Opipari, A. W.Jr., Hu, H. M., Yabkowitz, R., and Dixit, V. M.. 1992. The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J. Biol. Chem. 267:12424–12427
   PubMed Web of Science ®Google Scholar
• Parker, G. A., Touitou R., and Allday M. J.. Epstein-Barr virus EBNA-3C can induce nuclear division divorced from cytokinesis. Oncogene, in press.
   Google Scholar
• Pokrovskaja, K., Okan, I., Kashuba, E., Lowbeer, M., Klein, G., and Szekely, L.. 1999. Epstein-Barr virus infection and mitogen stimulation of normal B cells induces wild-type p53 without subsequent growth arrest or apoptosis. J. Gen. Virol. 80:987–995
   PubMedGoogle Scholar
• Rhind, N., and Russell, P.. 1998. Mitotic DNA damage and replication checkpoints in yeast. Curr. Opin. Cell Biol. 10:749–758
   PubMedGoogle Scholar
• Ruf, I. K., Rhyne, P. W., Yang, H., Borza, C. M., Hutt-Fletcher, L. M., Cleveland, J. L., and Sample, J. T.. 1999. Epstein-Barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma. Mol. Cell. Biol. 19:1651–1660
   PubMedGoogle Scholar
• Sorenson, C. M., Barry, M. A., and Eastman, A.. 1990. Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. J. Natl. Cancer Inst. 82:749–755
   PubMed Web of Science ®Google Scholar
• Strasser, A., Harris, A. W., Jacks, T., and Cory, S.. 1994. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 79:329–339
   PubMed Web of Science ®Google Scholar
• Strasser, A., Huang, D. C., and Vaux, D. L.. 1997. The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumourigenesis and resistance to chemotherapy. Biochim. Biophys. Acta 1333:F151–F178
   PubMed Web of Science ®Google Scholar
• Strasser-Wozak, E. M., Hartmann, B. L., Geley, S., Sgonc, R., Bock, G., Santos, A. J., Hattmannstorfer, R., Wolf, H., Pavelka, M., and Kofler, R.. 1998. Irradiation induces G2/M cell cycle arrest and apoptosis in p53-deficient lymphoblastic leukemia cells without affecting Bcl-2 and Bax expression. Cell Death Differ. 5:687–693
   PubMedGoogle Scholar
• Tewari, M., Quan, L. T., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D. R., Poirier, G. G., Salvesen, G. S., and Dixit, V. M.. 1995. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81:801–809
   PubMed Web of Science ®Google Scholar
• Vousden, K. H.. 1995. Regulation of the cell cycle by viral oncoproteins. Semin. Cancer Biol. 6:109–116
   PubMedGoogle Scholar
• Wang, F., Gregory, C., Sample, C., Rowe, M., Liebowitz, D., Murray, R., Rickinson, A., and Kieff, E.. 1990. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J. Virol. 64:2309–2318
   PubMed Web of Science ®Google Scholar
• Wang, J. Y.. 1998. Cellular responses to DNA damage. Curr. Opin. Cell Biol. 10:240–247
   PubMedGoogle Scholar
• Wang, S., Rowe, M., and Lundgren, E.. 1996. Expression of the Epstein Barr virus transforming protein LMP1 causes a rapid and transient stimulation of the Bcl-2 homologue Mcl-1 levels in B-cell lines. Cancer Res. 56:4610–3
   PubMed Web of Science ®Google Scholar
• Weinstein, J. N., Myers, T. G., O'Connor, P. M., Friend, S. H., Fornace, A. J.Jr., Kohn, K. W., Fojo, T., Bates, S. E., Rubinstein, L. V., Anderson, N. L., Buolamwini, J. K., van Osdol, W. W., Monks, A. P., Scudiero, D. A., Sausville, E. A., Zaharevitz, D. W., Bunow, B., Viswanadhan, V. N., Johnson, G. S., Wittes, R. E., and Paull, K. D.. 1997. An information-intensive approach to the molecular pharmacology of cancer. Science 275:343–349
   PubMed Web of Science ®Google Scholar
• Yuan, Z. M., Shioya, H., Ishiko, T., Sun, X., Gu, J., Huang, Y. Y., Lu, H., Kharbanda, S., Weichselbaum, R., and Kufe, D.. 1999. p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage. Nature 399:814–817
   PubMed Web of Science ®Google Scholar